| Arteriovenous malformation identification after conservative management of placenta percreta with uterine artery embolization and adjunctive therapy. | |
| | |
MedLine Citation:
|
PMID: 21349491 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Placenta percreta is a complication of pregnancy with significant morbidity and mortality rates. Conservative management may be considered when fertility preservation is desired or to possibly reduce morbidity when there is invasion of pelvic structures. We present 3 cases of antenatally diagnosed placenta percreta that were managed conservatively. A finding after the operation included the identification of arteriovenous malformations. |
| | |
Authors:
|
James T Barber; Terry B Tressler; Gregory S Willis; Francis J Martinez; David B Peisner; Jay D Goodman; Claudia D Taboada |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2011-02-24 |
Journal Detail:
|
Title: American journal of obstetrics and gynecology Volume: 204 ISSN: 1097-6868 ISO Abbreviation: Am. J. Obstet. Gynecol. Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-07-26 Completed Date: 2011-10-07 Revised Date: 2012-01-04 |
Medline Journal Info:
|
Nlm Unique ID: 0370476 Medline TA: Am J Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: e4-8 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2011 Mosby, Inc. All rights reserved. |
Affiliation:
|
Pinnacle Hospital, Department of Obstetrics and Gynecology, Sections of Maternal Fetal Medicine, Gynecologic Oncology, Department of Radiology, Section of Interventional Radiology, Harrisburg, PA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antineoplastic Agents, Phytogenic / therapeutic use Arteriovenous Malformations / diagnosis* Cesarean Section Etoposide / therapeutic use Female Humans Hysterectomy Placenta Accreta / therapy* Postpartum Hemorrhage / therapy* Pregnancy Treatment Outcome Uterine Artery Embolization* |
| Chemical | |
Reg. No./Substance:
|
0/Antineoplastic Agents, Phytogenic; 33419-42-0/Etoposide |
| Comments/Corrections | |
Comment In:
|
Am J Obstet Gynecol. 2011 Dec;205(6):e13; author reply e13-4
[PMID:
21861963
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Blood protein profiles of infants born before 28th weeks differ by pregnancy complication.
Next Document: Preoperative and postoperative predictors of satisfaction after surgical treatment of stress urinary...